Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues its relentless commitment to providing laboratories of all sizes with individualized and tailored support to meet the evolving list of regional and global compliance requirements.
Novartis strikes a $103M deal for bluebird’s PRV — if it wins one
An FDA decision on bluebird bio’s third gene therapy isn’t expected until December, but Novartis has already locked up a potential priority review voucher that
October 31, 2023